Genevieve M. Boland

CRISPR Screens Identify Essential Cell Growth Mediators in BRAF-inhibitor Resistant Melanoma

Myles Brown, Nicole Traugh, Sailing Shi, 2019, bioRxiv.

Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.

Jason W. Locasale, Sayan Mukherjee, Lorin Crawford, 2017, Cell reports.

Melanoma: Advances in Targeted Therapy and Molecular Markers

Genevieve M. Boland, G. Boland, D. DePeralta, 2015, Annals of Surgical Oncology.

PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas

Zhi Wei, Gordon Mills, Yiling Lu, 2017, Nature.